Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Flucytosine ER + vocimagene amiretrorepvec by Denovo Biopharma for High-Grade Glioma: Likelihood of Approval
Flucytosine ER + vocimagene amiretrorepvec is under clinical development by Denovo Biopharma and currently in Phase I for High-Grade Glioma....